2026 NPPES data Family Medicine Physician NPI 1417076738 M.D.
Verify on CMS →

RUPINDER CHEEMA, M.D.

Family Medicine Physician in ROSEVILLE, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
959
Medicare Part D claims · 52 beneficiaries · Family Medicine Physician avg: 3K
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

RUPINDER CHEEMA, M.D. filed 959 Medicare Part D claims in 2023 as a Family Medicine Physician in ROSEVILLE, California, prescribing 84% generic.

959
Part D claims, 2023
84%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RUPINDER CHEEMA, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

959 Top 25% higher than 75% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

RUPINDER CHEEMA, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RUPINDER CHEEMA, M.D.?

Quality data not reported

NPI registry status

Active

Issued 03/28/2007

NPI 1417076738

Primary specialty

Family Medicine Physician

High-volume

147,640 US NPIs in this specialty

Medicare Part D claims

959 72% vs specialty avg

2023 prescription claims

Specialty avg: 3,418

Specialty distribution in California

How Family Medicine Physician compares to other specialties among California providers

California providers

Family Medicine Physician share within California

1. Family Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Family Medicine Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Family Medicine Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Family Medicine Physician ABMS/AOA estimate

Est. board-certified rate (Family Medicine Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Family Medicine Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RUPINDER CHEEMA, M.D. appears in the CMS NPPES registry as a Family Medicine Physician provider holding M.D. credentials at 3001 DOUGLAS BLVD STE 325, ROSEVILLE, CA, 95661, with a listed phone of (916) 241-9844. NPI 1417076738 was issued on 03/28/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CHEEMA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 959 prescription claims written by this provider, covering 52 Medicare beneficiaries and totaling roughly $78K in drug spend, split 16% brand-name and 84% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Family Medicine Physician is a high-volume specialty nationwide, with 147,640 enrolled providers across 56 states and an average of 3,418 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3001 DOUGLAS BLVD STE 325
ROSEVILLE, CA 95661

Provider Details

NPI 1417076738
Specialty Family Medicine Physician
Credentials M.D.
Gender Female
NPI Issued 03/28/2007

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to RUPINDER CHEEMA, M.D.. To verify RUPINDER CHEEMA, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

RUPINDER CHEEMA, M.D. — brand share 16.0%
Specialty average (est.)

16% brand-name claims vs 84% generic, on 959 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

959
Total Claims
$78K
Total Drug Cost
52
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
962
Total Day Supply
23,435
Brand vs Generic
16% brand / 84% generic
Brand Drug Cost
$52K
Generic Drug Cost
$26K

Patient Demographics

Average Patient Age
73.8 years
Avg HCC Risk Score
2.49
Gender Split
54% female / 46% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What RUPINDER CHEEMA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Amlodipine Besylate
68
Levothyroxine Sodium
64
Gabapentin
57
Furosemide
42
Potassium Chloride
39
Atorvastatin Calcium
34
Pantoprazole Sodium
32
Famotidine
30
Metoprolol Succinate
29
Levetiracetam
28

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Family Medicine Physician Overview

How RUPINDER CHEEMA, M.D. fits within the Family Medicine Physician landscape nationally.

147,640
Family Medicine Physician Providers in US
56
States with Family Medicine Physician
3,418
Avg Claims per Provider

RUPINDER CHEEMA, M.D.'s 959 claims are below the specialty average of 3,418.

Nearby Family Medicine Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as CHEEMA.

Compare Family Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RUPINDER CHEEMA, M.D.'s specialty?
RUPINDER CHEEMA, M.D. specializes in Family Medicine Physician and practices in ROSEVILLE, California. Credentials: M.D..
How much does RUPINDER CHEEMA, M.D. prescribe under Medicare Part D?
In 2023, RUPINDER CHEEMA, M.D. wrote 959 Medicare Part D claims totaling $78K in drug costs for 52 beneficiaries.
Where is RUPINDER CHEEMA, M.D. located?
RUPINDER CHEEMA, M.D. is located at 3001 DOUGLAS BLVD STE 325, ROSEVILLE, CA, 95661. Phone: (916) 241-9844.
What is RUPINDER CHEEMA, M.D.'s NPI number?
RUPINDER CHEEMA, M.D.'s National Provider Identifier (NPI) is 1417076738, issued on 03/28/2007.
Does RUPINDER CHEEMA, M.D. prescribe more brand-name or generic drugs?
RUPINDER CHEEMA, M.D.'s prescribing is 16% brand-name and 84% generic drugs by claim count, with $52K in brand drug costs.
How many Family Medicine Physician providers are there in the US?
There are 147,640 Family Medicine Physician providers across 56 states in the US. The average Family Medicine Physician provider writes 3,418 Medicare Part D claims per year.
What drugs does RUPINDER CHEEMA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, RUPINDER CHEEMA, M.D.'s most frequently prescribed drugs include Amlodipine Besylate, Levothyroxine Sodium, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RUPINDER CHEEMA, M.D. accept Medicare?
RUPINDER CHEEMA, M.D. appears in CMS Medicare data with 959 Part D claims and 52 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RUPINDER CHEEMA, M.D.'s credentials?
RUPINDER CHEEMA, M.D.'s NPI is 1417076738 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology